Company Profile
Biodesix Stock Price, News & Catalysts
- Ticker:
- BDSX
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
23.25 USD (-3.13%)
Close
Last updated: August 17, 2026
160M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, BDSX closed down 3.13% at $23.25. No new same-company headline was identified in the current news window.
Company overview
Lung-Disease Diagnostics
Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations.
Diagnostic Testing
The company provides blood-based and other diagnostic tests that help physicians characterize disease, guide treatment and monitor patients. Its commercial laboratory infrastructure supports ordering, sample processing and reporting for routine clinical use.
Development Services
Biodesix also works with biopharmaceutical, life-sciences and research organizations to develop diagnostics, tools and therapeutics. These services combine scientific, technological and operational capabilities and can support biomarker strategy from research through clinical development.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Biodesix (BDSX)?
Biodesix (BDSX) most recently closed at 23.25 USD, a -3.13% move versus the previous session.
What is the market cap of Biodesix (BDSX)?
Biodesix currently has a market capitalization of 160M USD on BioPharmSignal.
What does Biodesix do?
Lung-Disease Diagnostics Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology. Its tests combine multiple analytical technologies with clinical evidence and laboratory operations. Diagnostic Testing The company provides blood-based and other diagnostic...
On which exchange is BDSX stock listed?
Biodesix (BDSX) is associated with NASDAQ, United States, MedTech.
What is Lung-Disease?
Lung-Disease Diagnostics Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology.
Which conditions is Biodesix targeting with Lung-Disease?
Biodesix is associated with oncology based on its company overview and current catalyst commentary.
What is Diagnostics?
Lung-Disease Diagnostics Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology.
What is Biodesix?
Lung-Disease Diagnostics Biodesix develops and commercializes diagnostic solutions intended to improve clinical decision-making, with a particular focus on lung disease and oncology.